Ibrutinib–rituximab treatment previously untreated CLL(Chronic Lymphocytic Leukemia) or SLL 이전에 치료받지 않은 CLL(만성 림프구성 백혈병) 또는 SLL에 대한 이브루티닙-리툭시맙 치료
Ibrutinib–rituximab treatment previously untreated CLL(Chronic Lymphocytic Leukemia) or SLL In this randomized trial involving patients 70 years of age or younger who had previously untreated CLL or SLL and did not have chromosome 17p13 deletion, ibrutinib–rituximab treatment was superior … Continued